- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07588542
PACU Discharge Readiness
May 8, 2026 updated by: David Glick, University of Illinois at Chicago
Development of Assessment Tools for Determining Outpatient Subjects' Home-Readiness After Receiving Anesthesia (Without Family or Friend to Drive Them Home)
The use of custom-created apps, neuropsychological testing, and clinical assessments will be evaluated as tools for determining the appropriateness of PACU discharge to home.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
1000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alexandra Barabanova
- Phone Number: 312-355-5377
- Email: barabano@uic.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- University of Illinois Chicago
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The individuals will be identified from the operating room (OR) schedule and approached in the pre-operative area (or earlier, when possible).
- Adult patients (18 years or older) listed for surgery and a planned 23-hour admission will be eligible for enrollment in this study.
- Subjects must be fluent in English and not have confounding sensory or neurological limitations to participation
Exclusion Criteria:
- Members of vulnerable populations or adults unable to consent will be included in this study.
- Subjects that do not speak English
- Subjects with neurological limirations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Neuro Assessment Group
|
This study's interventions will include a brief neuropsychological assessment, including pre-operative baseline and post-operative repeat assessment.
Additional assessments of memory and coordination using two custom apps and standard clinical assessments will also be conducted at each timepoint
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standardized neuropsychiatric testing WAIS SCWT SPWT TOPJ
Time Frame: 24 hours
|
comparison of results to baseline measurements of these four validated neuropsychiatric assessments
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Memory App
Time Frame: 24 hours
|
Use of a colored sequence presentation memory app to assess subjects return to baseline
|
24 hours
|
|
Flight Path App
Time Frame: 24 hours
|
Seated subject follows the flight path of a bird on an iPad app.
Comparisons made to baseline performance.
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2026
Primary Completion (Estimated)
April 1, 2031
Study Completion (Estimated)
April 1, 2032
Study Registration Dates
First Submitted
March 20, 2026
First Submitted That Met QC Criteria
May 8, 2026
First Posted (Actual)
May 14, 2026
Study Record Updates
Last Update Posted (Actual)
May 14, 2026
Last Update Submitted That Met QC Criteria
May 8, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 2025-1331
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Baseline
-
University of Sao PauloNewcastle UniversityNot yet recruiting
-
National Institute of Mental Health (NIMH)CompletedBaseline | Blocking Receptor BindingUnited States
-
National University of SingaporeUniversity of SfaxRecruitingBaseline/Control Phase | Intervention PhaseSingapore, France
-
University of California, DavisWithdrawn
-
Daiichi Sankyo, Inc.CompletedBaseline Epidemiologic AssessmentUnited States
-
Centre for Addiction and Mental HealthCompletedTechnology | BaselineCanada
-
Methodist Health SystemRecruitingBaseline ThrombocytopeniaUnited States
-
GBG Forschungs GmbHAstraZenecaRecruitingCCCA Assessed by Ki67 Drop Below <2.7% From BaselineGermany
-
University of Maryland, College ParkRecruitingAll Health Backgrounds to Determine a Baseline of Flatus ActivityUnited States
-
Hadassah Medical OrganizationUnknownDecrease in Heart Rate Below Baseline ValueIsrael
Clinical Trials on custom-created apps, neuropsychological testing, and clinical assessments
-
Northwell HealthNational Institutes of Health (NIH)RecruitingElectroconvulsive Therapy Treated PatientsUnited States
-
Thomas Jefferson UniversityUnknownCerebral Metastases PatientsUnited States
-
University of Michigan Rogel Cancer CenterCompletedBrain NeoplasmsUnited States
-
Olaf BlankeUniversity Hospital, Geneva; University Hospital Inselspital, Berne; Centre Hospitalier... and other collaboratorsUnknown
-
Northwell HealthMichael J. Fox Foundation for Parkinson's ResearchActive, not recruitingParkinson's DiseaseUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingPsychiatric Disorder | Adverse Drug Event | Family Members | Treatment Compliance | Cognition Disorder
-
Neurological Institute of AthensKing's College London; Uppsala University; Rabin Medical Center; University of... and other collaboratorsCompletedEpilepsy | Healthy | Sleep Disorder | Dementia | Alzheimer Disease | Circadian Rhythm DisordersUnited Kingdom, Israel, Greece, Spain
-
Washington University School of MedicineRutgers UniversityCompleted
-
IRCCS San RaffaeleIstituto Auxologico Italiano; Azienda Ospedaliera San Gerardo di Monza; IRCCS...Enrolling by invitationAmyotrophic Lateral Sclerosis (ALS) | Neurodegenerative Disease | Behavioral Variant Frontotemporal Dementia (bvFTD) | Primary Progressive Aphasia(PPA) | Progressive Supranuclear Palsy(PSP) | Cortical Basal Syndrome (CBS)Italy
-
Hospices Civils de LyonRecruitingAutoimmune Diseases | Genetic Disease | Autoinflammatory Disease | Systemic LupusFrance